HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip Schulman Selected Research

lintuzumab

6/2005Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip Schulman Research Topics

Disease

2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2011 - 06/2005
1Multiple Myeloma
02/2012
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2011
1Leukemia
03/2011
1Neoplasms (Cancer)
03/2011
1Fever (Fevers)
06/2005
1Hypotension (Low Blood Pressure)
06/2005
1Chills
06/2005
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2002

Drug/Important Bio-Agent (IBA)

2Bortezomib (Velcade)FDA Link
02/2012 - 04/2011
17,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
02/2012
1Thalidomide (Thalomid)FDA Link
02/2012
1liposomal doxorubicin (Doxil)FDA Link
02/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
02/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2011
1Prednisone (Sone)FDA LinkGeneric
04/2011
1Vincristine (Oncovin)FDA LinkGeneric
04/2011
1Rituximab (Mabthera)FDA Link
04/2011
1Gemtuzumab (Mylotarg)FDA Link
03/2011
1Cytarabine (Cytosar-U)FDA LinkGeneric
03/2011
1lintuzumabIBA
06/2005
1Monoclonal AntibodiesIBA
06/2005
1AntigensIBA
06/2002

Therapy/Procedure

1Induction Chemotherapy
06/2005
1Drug Therapy (Chemotherapy)
06/2005